Insilico Medcine( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced the first patient has been dosed in the global multicenter Phase I ...

Artificial intelligence as it is used today is considered “weak AI,” because it is generally designed to perform just one or two specific tasks as well as, and often better than, humans. At ...

Service specifications are important in clearly defining the standards of care expected from organisations funded by NHS England to provide specialised care. The specifications have been developed by ...